Cargando…

Comparison of the Outcome of Low Dose and High-Dose Corticosteroid in the Treatment of Idiopathic Granulomatous Mastitis

BACKGROUND: Idiopathic granulomatous mastitis (IGM) is a rare chronic inflammatory breast condition with unknown etiology. Different treatments including corticosteroids have been recommended with no universal consensus. In this study we evaluated the efficacy of low dose vs. high dose prednisolone...

Descripción completa

Detalles Bibliográficos
Autores principales: Montazer, Majid, Dadashzadeh, Maryam, Mousavi Toomatari, Seyed Ehsan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445984/
https://www.ncbi.nlm.nih.gov/pubmed/32334460
http://dx.doi.org/10.31557/APJCP.2020.21.4.993
_version_ 1783574092073402368
author Montazer, Majid
Dadashzadeh, Maryam
Mousavi Toomatari, Seyed Ehsan
author_facet Montazer, Majid
Dadashzadeh, Maryam
Mousavi Toomatari, Seyed Ehsan
author_sort Montazer, Majid
collection PubMed
description BACKGROUND: Idiopathic granulomatous mastitis (IGM) is a rare chronic inflammatory breast condition with unknown etiology. Different treatments including corticosteroids have been recommended with no universal consensus. In this study we evaluated the efficacy of low dose vs. high dose prednisolone in treatment of IGM. METHODS: In this randomized clinical trial, 30 female patients with IGM were randomly allocated to receive low dose or high dose prednisolone. First group received 5 mg daily prednisolone, while the second group received 50 mg for three days, 25 mg for the next three days and then 12.5 mg for further three days and 5 mg daily afterwards, both for two months. Patients were evaluated 2, 3, 6 and 12 months after treatment. The success and recurrence rate was compared between groups. RESULTS: High dose group had significantly higher rate of remission compared to low dose group (93.3% vs. 53.3%, p=0.03). One patient in high dose group and 5 patients in low dose group underwent lumpectomy due to persistent symptoms. Two other patients in low dose group received high dose treatment after three months due to no change in symptoms. Among patients with remission, recurrence was also significantly lower in high dose compared to low dose prednisolone (0% vs. 37.5%, p=0.04). CONCLUSION: High dose prednisolone has high success rate with lower recurrence in the treatment of IGM and could reduce the need for surgery. However, further studies are necessary to confirm these findings.
format Online
Article
Text
id pubmed-7445984
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-74459842020-09-02 Comparison of the Outcome of Low Dose and High-Dose Corticosteroid in the Treatment of Idiopathic Granulomatous Mastitis Montazer, Majid Dadashzadeh, Maryam Mousavi Toomatari, Seyed Ehsan Asian Pac J Cancer Prev Research Article BACKGROUND: Idiopathic granulomatous mastitis (IGM) is a rare chronic inflammatory breast condition with unknown etiology. Different treatments including corticosteroids have been recommended with no universal consensus. In this study we evaluated the efficacy of low dose vs. high dose prednisolone in treatment of IGM. METHODS: In this randomized clinical trial, 30 female patients with IGM were randomly allocated to receive low dose or high dose prednisolone. First group received 5 mg daily prednisolone, while the second group received 50 mg for three days, 25 mg for the next three days and then 12.5 mg for further three days and 5 mg daily afterwards, both for two months. Patients were evaluated 2, 3, 6 and 12 months after treatment. The success and recurrence rate was compared between groups. RESULTS: High dose group had significantly higher rate of remission compared to low dose group (93.3% vs. 53.3%, p=0.03). One patient in high dose group and 5 patients in low dose group underwent lumpectomy due to persistent symptoms. Two other patients in low dose group received high dose treatment after three months due to no change in symptoms. Among patients with remission, recurrence was also significantly lower in high dose compared to low dose prednisolone (0% vs. 37.5%, p=0.04). CONCLUSION: High dose prednisolone has high success rate with lower recurrence in the treatment of IGM and could reduce the need for surgery. However, further studies are necessary to confirm these findings. West Asia Organization for Cancer Prevention 2020-04 /pmc/articles/PMC7445984/ /pubmed/32334460 http://dx.doi.org/10.31557/APJCP.2020.21.4.993 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Montazer, Majid
Dadashzadeh, Maryam
Mousavi Toomatari, Seyed Ehsan
Comparison of the Outcome of Low Dose and High-Dose Corticosteroid in the Treatment of Idiopathic Granulomatous Mastitis
title Comparison of the Outcome of Low Dose and High-Dose Corticosteroid in the Treatment of Idiopathic Granulomatous Mastitis
title_full Comparison of the Outcome of Low Dose and High-Dose Corticosteroid in the Treatment of Idiopathic Granulomatous Mastitis
title_fullStr Comparison of the Outcome of Low Dose and High-Dose Corticosteroid in the Treatment of Idiopathic Granulomatous Mastitis
title_full_unstemmed Comparison of the Outcome of Low Dose and High-Dose Corticosteroid in the Treatment of Idiopathic Granulomatous Mastitis
title_short Comparison of the Outcome of Low Dose and High-Dose Corticosteroid in the Treatment of Idiopathic Granulomatous Mastitis
title_sort comparison of the outcome of low dose and high-dose corticosteroid in the treatment of idiopathic granulomatous mastitis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445984/
https://www.ncbi.nlm.nih.gov/pubmed/32334460
http://dx.doi.org/10.31557/APJCP.2020.21.4.993
work_keys_str_mv AT montazermajid comparisonoftheoutcomeoflowdoseandhighdosecorticosteroidinthetreatmentofidiopathicgranulomatousmastitis
AT dadashzadehmaryam comparisonoftheoutcomeoflowdoseandhighdosecorticosteroidinthetreatmentofidiopathicgranulomatousmastitis
AT mousavitoomatariseyedehsan comparisonoftheoutcomeoflowdoseandhighdosecorticosteroidinthetreatmentofidiopathicgranulomatousmastitis